← Back to Search

Photoacoustic Imaging for Breast Cancer

N/A
Recruiting
Led By Ermelinda Bonaccio
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women with clinically suspicious or confirmed breast cancer masses (that have not been surgically removed) and will/have already undergo/undergone breast magnetic resonance imaging (MRI).
Be older than 18 years old
Must not have
Individuals who are not yet adults (infants, children, teenagers).
Women who have had lumpectomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Summary

This trial is testing a new way to image breasts, which may be especially helpful for women with dense breasts.

Who is the study for?
This trial is for women with suspected or confirmed breast cancer who have not had the mass surgically removed and have undergone or will undergo an MRI. It excludes non-English speakers, prisoners, minors, pregnant women (to avoid unknown risks), those with recent breast implants, and adults unable to consent.
What is being tested?
The study is testing photoacoustic imaging on the breast tissue of both healthy subjects and patients with breast cancer. This technique combines light and sound to potentially improve detection in dense breasts where mammography may be less sensitive.
What are the potential side effects?
There are no direct benefits from participating in this study; however, there are also no known significant side effects associated with photoacoustic imaging as it's a non-invasive procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a breast mass that hasn't been removed and will/have had a breast MRI.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under the age of 18.
Select...
I have had a lumpectomy.
Select...
I understand there's no direct benefit from the study and I speak English.
Select...
I am unable to give consent for medical procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Identify photoacoustic features of breast malignancies

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diagnostic (photoacoustic imaging of the breast)Experimental Treatment1 Intervention
Participants undergo photoacoustic imaging of the breast over 30 minutes. At subject's discretion, imaging may repeat for a total of 10 studies, each in a separate day.

Find a Location

Who is running the clinical trial?

Susan G. Komen Breast Cancer FoundationOTHER
67 Previous Clinical Trials
220,038 Total Patients Enrolled
41 Trials studying Breast Cancer
215,075 Patients Enrolled for Breast Cancer
Roswell Park Cancer InstituteLead Sponsor
408 Previous Clinical Trials
32,218 Total Patients Enrolled
10 Trials studying Breast Cancer
1,638 Patients Enrolled for Breast Cancer
Ermelinda BonaccioPrincipal InvestigatorRoswell Park Cancer Institute

Media Library

Photoacoustic Imaging Clinical Trial Eligibility Overview. Trial Name: NCT03897270 — N/A
Breast Cancer Research Study Groups: Diagnostic (photoacoustic imaging of the breast)
Breast Cancer Clinical Trial 2023: Photoacoustic Imaging Highlights & Side Effects. Trial Name: NCT03897270 — N/A
Photoacoustic Imaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT03897270 — N/A
~22 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top